Mondino A - Search Results

1

Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes.

Camporeale A, Boni A, Iezzi G, Degl'Innocenti E, Grioni M, Mondino A, Bellone M. Camporeale A, et al. Among authors: mondino a. Cancer Res. 2003 Jul 1;63(13):3688-94. Cancer Res. 2003. PMID: 12839960

2

The immunogenicity of dendritic cell-based vaccines is not hampered by doxorubicin and melphalan administration.

Casati A, Zimmermann VS, Benigni F, Bertilaccio MT, Bellone M, Mondino A. Casati A, et al. Among authors: mondino a. J Immunol. 2005 Mar 15;174(6):3317-25. doi: 10.4049/jimmunol.174.6.3317. J Immunol. 2005. PMID: 15749863

3

Phenotype and homing of CD4 tumor-specific T cells is modulated by tumor bulk.

Benigni F, Zimmermann VS, Hugues S, Caserta S, Basso V, Rivino L, Ingulli E, Malherbe L, Glaichenhaus N, Mondino A. Benigni F, et al. Among authors: mondino a. J Immunol. 2005 Jul 15;175(2):739-48. doi: 10.4049/jimmunol.175.2.739. J Immunol. 2005. PMID: 16002669

4

Tumors hamper the immunogenic competence of CD4+ T cell-directed dendritic cell vaccination.

Zimmermann VS, Casati A, Schiering C, Caserta S, Hess Michelini R, Basso V, Mondino A. Zimmermann VS, et al. Among authors: mondino a. J Immunol. 2007 Sep 1;179(5):2899-909. doi: 10.4049/jimmunol.179.5.2899. J Immunol. 2007. PMID: 17709504

5

Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer.

Bellone M, Mondino A, Corti A. Bellone M, et al. Among authors: mondino a. Trends Immunol. 2008 May;29(5):235-41. doi: 10.1016/j.it.2008.02.003. Epub 2008 Mar 28. Trends Immunol. 2008. PMID: 18375183 Review.

6

Synthetic CD4+ T cell-targeted antigen-presenting cells elicit protective antitumor responses.

Caserta S, Alessi P, Guarnerio J, Basso V, Mondino A. Caserta S, et al. Among authors: mondino a. Cancer Res. 2008 Apr 15;68(8):3010-8. doi: 10.1158/0008-5472.CAN-07-5796. Cancer Res. 2008. PMID: 18413771

7

IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4(+) T cells.

Caserta S, Alessi P, Basso V, Mondino A. Caserta S, et al. Among authors: mondino a. Eur J Immunol. 2010 Feb;40(2):470-9. doi: 10.1002/eji.200939801. Eur J Immunol. 2010. PMID: 19950184 Free article.

8

Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumors.

Hess Michelini R, Freschi M, Manzo T, Jachetti E, Degl'Innocenti E, Grioni M, Basso V, Bonini C, Simpson E, Mondino A, Bellone M. Hess Michelini R, et al. Among authors: mondino a. Cancer Res. 2010 May 1;70(9):3505-14. doi: 10.1158/0008-5472.CAN-09-4253. Epub 2010 Apr 13. Cancer Res. 2010. PMID: 20388780

9

Antigen-experienced CD4(+) T cells limit naïve T-cell priming in response to therapeutic vaccination in vivo.

Schiering C, Guarnerio J, Basso V, Muzio L, Mondino A. Schiering C, et al. Among authors: mondino a. Cancer Res. 2010 Aug 1;70(15):6161-70. doi: 10.1158/0008-5472.CAN-09-4398. Epub 2010 Jul 14. Cancer Res. 2010. PMID: 20631073

10

Concurrent allorecognition has a limited impact on posttransplant vaccination.

Manzo T, Hess Michelini R, Basso V, Ricupito A, Chai JG, Simpson E, Bellone M, Mondino A. Manzo T, et al. Among authors: mondino a. J Immunol. 2011 Feb 1;186(3):1361-8. doi: 10.4049/jimmunol.1002030. Epub 2011 Jan 5. J Immunol. 2011. PMID: 21209285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters